Although the FGF21 test is not a routine and standard test in hospital laboratories, current studies have observed that FGF21 is upregulated in metabolic and other disorders and realized its potential value as a diagnostic and prognostic biomarker for metabolic diseases. The gene discussed is FGF21; the disease is Other metabolic disease.